v3.26.1
STOCKHOLDERS' EQUITY - Share Consolidation Retroactively Adjusted Basis (Details) - USD ($)
1 Months Ended 12 Months Ended
Aug. 26, 2024
Feb. 28, 2025
Dec. 31, 2025
Dec. 31, 2024
Increase (Decrease) in Shareholders' Equity        
Balance at the beginning     $ 3,581,591 $ 3,877,205
Share-based compensation May 14, 2024       24,761
Share-based compensation to executive officers May 31, 2024       363,169
Scholar 08/26/2024       26,164
Private placement September 18, 2024       406,675
Exercise of Series A Warrants - Reduce of Warrants liabilities     126,180  
Balance at the end     $ 4,256,282 3,581,591
Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise of Series A Warrants - Reduce of Warrants liabilities   $ 126,180    
Number of warrants reclassed from liability     1,500,000  
Ordinary Shares        
Increase (Decrease) in Shareholders' Equity        
Balance at the beginning     $ 25,220 11,675
Share-based compensation May 14, 2024 (Shares) 27      
Share-based compensation May 14, 2024 $ 24     23
Share-based compensation - Employees May 31, 2024       890
Share-based compensation to executive officers May 31, 2024       286
Scholar 08/26/2024       24
Private placement September 18, 2024       2,722
Adjustment for share consolidation     4 3
Balance at the end     26,724 25,220
Ordinary Shares | Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants, one     600  
Exercise warrants, two     $ 900 1,039
Ordinary Shares | Series B Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants, one       $ 8,558
Ordinary Shares | Pro Forma        
Increase (Decrease) in Shareholders' Equity        
Balance (shares)     25,216,523 11,675,216
Share-based compensation May 14, 2024 (Shares)       23,360
Share-based compensation - Employees May 31, 2024 (Shares)       889,960
Share-based compensation to executive officers May 31, 2024 (Shares)       285,960
Scholar 08/26/2024 (Shares)       23,360
Private placement September 18, 2024 (Shares)       2,722,224
Balance (shares)     26,716,523 25,216,523
Ordinary Shares | Pro Forma | Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one     600,000  
Exercise warrants (Shares) , two     900,000 1,038,889
Ordinary Shares | Pro Forma | Series B Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one       8,557,554
Ordinary Shares | Share Consolidation (25:1)        
Increase (Decrease) in Shareholders' Equity        
Balance (shares)     1,008,665 467,009
Share-based compensation May 14, 2024 (Shares)       935
Share-based compensation - Employees May 31, 2024 (Shares)       35,599
Share-based compensation to executive officers May 31, 2024 (Shares)       11,439
Scholar 08/26/2024 (Shares)       935
Private placement September 18, 2024 (Shares)       108,889
Adjustment for share consolidation (in shares)     21  
Balance (shares)     1,068,686 1,008,665
Ordinary Shares | Share Consolidation (25:1) | Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one     24,000  
Exercise warrants (Shares) , two     36,000 41,556
Ordinary Shares | Share Consolidation (25:1) | Series B Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one       342,303
Ordinary Shares | Share Consolidation (35:1)        
Increase (Decrease) in Shareholders' Equity        
Balance (shares)     28,823 13,344
Share-based compensation May 14, 2024 (Shares)       27
Share-based compensation - Employees May 31, 2024 (Shares)       1,016
Share-based compensation to executive officers May 31, 2024 (Shares)       328
Scholar 08/26/2024 (Shares)       27
Private placement September 18, 2024 (Shares)       3,112
Adjustment for share consolidation (in shares)     4  
Balance (shares)     30,542 28,823
Ordinary Shares | Share Consolidation (35:1) | Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one     686  
Exercise warrants (Shares) , two     1,029 1,188
Ordinary Shares | Share Consolidation (35:1) | Series B Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants (Shares) , one       9,781
Additional Paid in Capital        
Increase (Decrease) in Shareholders' Equity        
Balance at the beginning     $ 9,870,993 $ 6,845,394
Share-based compensation May 14, 2024 $ 26,140     24,738
Share-based compensation - Employees May 31, 2024       1,129,359
Share-based compensation to executive officers May 31, 2024       362,883
Scholar 08/26/2024       26,140
Private placement September 18, 2024       403,953
Exercise of Series A Warrants - Reduce of Warrants liabilities     126,180  
Deconsolidation of VIE     (2,572,437)  
Adjustment for share consolidation     (4) (3)
Balance at the end     7,747,232 9,870,993
Additional Paid in Capital | Series A Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants, one     129,000  
Exercise warrants, two     $ 193,500 89,397
Exercise of Series A Warrants - Reduce of Warrants liabilities       223,361
Additional Paid in Capital | Series B Warrants        
Increase (Decrease) in Shareholders' Equity        
Exercise warrants, one       $ 765,771